Cure CMD International Research Grants
Funds accredited research institutions advancing treatments and care for congenital muscular dystrophy.
Cure CMD's international research grant programme supports accredited scientific institutions working on specific forms of congenital muscular dystrophy. Its 2026 request for applications contains two separate grants: one for congenital-onset laminopathies and one for congenital-onset dystroglycanopathies. Each grant has its own award limit, while both use a letter of intent followed by an invited…
Each grant below is a distinct funding opportunity with its own eligibility, scope, and deliverables.
Funds accredited research institutions developing treatments for congenital dystroglycanopathies with grants up to $50,000.
Funds accredited research institutions developing treatments and care improvements for congenital-onset laminopathies with grants up to $100,000.